47 completed, 38 recruiting, 24 active not recruiting, 12 terminated. 63 Not applicable, 32 Phase 2, 8 Early Phase 1, 7 Phase 1, 6 Phase 3.
Follow Prostate Carcinoma: new trials by email Literature Review of Prostate Carcinoma trials Research Report on Prostate Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Remote Screening and Navigation to Increase Trial Enrollment, INVITE Trial Electronic Health Record Review, Patient Navigation, Prescreen - Bladder Carcinoma, Prostate Carcinoma | Not applicable | Not yet recruiting | Fred Hutchinson Cancer Center | 50 | 2027-01-01 | 2026-11-06 |
| Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial Biopsy Procedure, Diagnostic Procedure, Electronic Health Record Review - Prostate Carcinoma | Not applicable | Recruiting | University of Michigan Rogel Cancer Center | 800 | 2026-12-01 | 2026-10-15 |
| CT- Versus MRI-Based Planning for High-Dose-Rate Prostate Brachytherapy for Prostate Cancer Magnetic Resonance Imaging, Questionnaire Administration - Prostate Carcinoma, Stage I Prostate Cancer AJCC v8 | Not applicable | Recruiting | Emory University | 100 | 2026-10-22 | 2026-11-02 |
| Evaluating Prostate Cancer Patient Natural Killer Cell Function Across Racial Background and Addressing Functional Disparities With Trispecific Killer Engagers Non-Interventional Study - Prostate Carcinoma | Recruiting | Masonic Cancer Center, University of Minnesota | 45 | 2026-10-08 | 2026-11-02 | |
| Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer ultiparametric Magnetic Resonance Imaging, Perflutren lipid microsphere, Transrectal Ultrasound - Prostate Carcinoma | Phase 3 | Not yet recruiting | Thomas Jefferson University | 300 | 2026-10-01 | 2026-08-25 |
| Transperineal Micro-ultrasound for the Detection of Prostate Cancer During Biopsy Biopsy of Prostate, Magnetic Resonance Imaging, Micro-ultrasound Imaging - Prostate Carcinoma | Not applicable | Withdrawn | Roswell Park Cancer Institute | 2026-08-18 | 2026-10-29 | |
| A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men Best Practice, Discussion, Survey Administration - Prostate Carcinoma | Not applicable | Recruiting | Mayo Clinic | 200 | 2026-04-24 | 2026-09-25 |
| GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer Socially enhanced supervised group exercise, Exercise Intervention, Unsupervised independent exercise - Prostate Carcinoma | Not applicable | Recruiting | OHSU Knight Cancer Institute | 150 | 2026-04-15 | 2026-05-06 |
| Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer Behavioral Intervention, Biospecimen Collection, Electronic Health Record Review - Prostate Carcinoma | Not applicable | Recruiting | M.D. Anderson Cancer Center | 108 | 2026-02-02 | 2026-09-25 |
| Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy fezolinetant - reference formulation, Placebo - Prostate Cancer, Prostate Cancer (Adenocarcinoma) | Phase 2 | Recruiting | Shehzad Basaria, M.D. | 60 | 2026-01-14 | 2026-08-17 |
| A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients Educational Intervention, Electronic Health Record Review, Follow-Up - Breast Carcinoma, Colorectal Carcinoma | Not applicable | Active not recruiting | University of Michigan Rogel Cancer Center | 71 | 2026-01-09 | 2026-11-09 |
| The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas Cancer Therapeutic Procedure, Questionnaire Administration - Amyloidosis, Basal Cell Carcinoma | Phase 2 | Recruiting | Mayo Clinic | 27 | 2025-12-18 | 2026-09-30 |
| Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement Spot Delete planning for proton therapy, Traditional proton treatment planning system - Prostate Cancer, Prostate Adenocarcinoma | Not applicable | Recruiting | Covenant Health Cancer Center | 500 | 2025-12-15 | 2025-12-18 |
| Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane Chemotherapy Best Practice, Oral Cryotherapy, Survey Administration - Prostate Carcinoma | Not applicable | Completed | City of Hope Medical Center | 2 | 2025-12-08 | 2026-10-16 |
| Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial Biopsy of Prostate, Biospecimen Collection, Computed Tomography - Prostate Carcinoma | Early Phase 1 | Recruiting | Jonsson Comprehensive Cancer Center | 30 | 2025-11-14 | 2026-03-10 |
| Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial Antiandrogen Therapy, Behavioral Intervention, Biospecimen Collection - Prostate Carcinoma, Recurrent Prostate Carcinoma | Phase 2 | Recruiting | City of Hope Medical Center | 60 | 2025-11-05 | 2026-08-17 |
| An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer. Computed Tomography, Fluorine F 18 Flotufolastat, Positron Emission Tomography - Prostate Carcinoma | Phase 2 | Recruiting | Jonsson Comprehensive Cancer Center | 81 | 2025-10-09 | 2026-09-29 |
| MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER Trial Targeted Prostate Biopsy, Prostate Imaging Reporting & Data System, Deep Learning Artificial Intelligence - Prostate Carcinoma | Not applicable | Recruiting | University of Southern California | 130 | 2025-09-19 | 2026-09-01 |
| Screening and Staging of Benign vs Malignant Pelvic Abnormalities Non-Interventional Study - Endometrial Carcinoma, Prostate Carcinoma | Recruiting | Mayo Clinic | 60 | 2025-09-04 | 2026-02-17 | |
| Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers Computed Tomography, Fludeoxyglucose F-18, Gallium Ga 68 FAPi-46 - Anal Carcinoma, Bladder Carcinoma | Phase 1 | Active not recruiting | Jonsson Comprehensive Cancer Center | 30 | 2025-08-01 | 2026-10-20 |
Showing 20 of 142. Sign in to see all of them.
Prostatic Neoplasms (142) · Breast Neoplasms (19) · Pancreatic Neoplasms (11) · Colorectal Neoplasms (10) · Lung Neoplasms (8) · Ovarian Neoplasms (8) · Carcinoma, Hepatocellular (7) · Urinary Bladder Neoplasms (7) · Carcinoma, Renal Cell (6) · Endometrial Neoplasms (6) · Uterine Cervical Neoplasms (6) · Stomach Neoplasms (5) · Carcinoma, Transitional Cell (4) · Colonic Neoplasms (4) · Melanoma (4)
Genital Diseases (142) · Genital Diseases, Male (142) · Genital Neoplasms, Male (142) · Male Urogenital Diseases (142) · Urogenital Diseases (142) · Neoplasms by Site (141) · Prostatic Diseases (141) · Neoplasms (140) · Urogenital Neoplasms (140) · Skin Diseases (21) · Skin and Connective Tissue Diseases (21) · Breast Diseases (19) · Digestive System Diseases (18) · Female Urogenital Diseases (18) · Female Urogenital Diseases and Pregnancy Complications (18)
Magnetic Resonance Spectroscopy (22) · Specimen Handling (14) · Early Intervention, Educational (10) · Methods (8) · Educational Status (7) · Biopsy (6) · Standard of Care (6) · Interviews as Topic (5) · Practice Guidelines as Topic (5) · Radiotherapy (5) · X-Rays (5) · gallium 68 PSMA-11 (5) · 68Ga-DKFZ-PSMA-11 (4) · Behavior Therapy (4) · Radiation (4)
Mayo Clinic (17) · OHSU Knight Cancer Institute (12) · Jonsson Comprehensive Cancer Center (11) · City of Hope Medical Center (9) · M.D. Anderson Cancer Center (8) · University of Southern California (7) · National Cancer Institute (NCI) (6) · Fred Hutchinson Cancer Center (5) · Thomas Jefferson University (5) · ECOG-ACRIN Cancer Research Group (3) · Emory University (3) · Ohio State University Comprehensive Cancer Center (3) · Roswell Park Cancer Institute (3) · University of Michigan Rogel Cancer Center (3) · Case Comprehensive Cancer Center (2)
United States (120) · China (5) · France (3) · Germany (3) · Finland (2) · Guam (2) · Italy (2) · Netherlands (2) · Puerto Rico (2) · Spain (2) · Brazil (1) · Canada (1) · India (1) · Singapore (1) · Switzerland (1)
Jeremie Calais (5) · Kerri Winters-Stone (5) · William Dale (3) · Andre Luis Abreu, MD (2) · Folakemi T. Odedina, Ph.D. (2) · Folakemi T. Odedina, PhD (2) · Khurshid A Guru (2) · Wayne Brisbane (2) · Alicia K Morgans (1) · Amir Goldkorn, MD (1) · Amy Leader, DrPH, MPH (1) · Amy M Ross, Ph.D. (1) · Ana M. Aparicio, MD (1) · Andrei Iagaru (1) · Antti S Rannikko, MD, PhD (1)
PMID 34741653, PMID 41698328, PMID 15655554, PMID 17077240, PMID 17932357, PMID 18930581, PMID 19292893, PMID 19297565, PMID 19305319, PMID 19359544, PMID 19399748, PMID 19404219, PMID 19424173, PMID 19433838, PMID 19996060, PMID 20494998, PMID 20571134, PMID 21604935, PMID 21642681, PMID 22031728, PMID 22612596, PMID 22894553, PMID 22902761, PMID 23063623, PMID 23186377, PMID 23993734, PMID 24623848, PMID 24740205, PMID 25104109, PMID 25123333, PMID 25687533, PMID 25762808, PMID 25888263, PMID 25937426, PMID 26255045, PMID 26586415, PMID 26659347, PMID 27160946, PMID 28647394, PMID 29147764, PMID 29800214, PMID 30125350, PMID 30274964, PMID 30442638, PMID 30502933, PMID 30592477, PMID 30943843, PMID 31164172, PMID 32463741, PMID 32632561
P30CA014089 (7), P30CA033572 (7), P30CA015704 (4), P30CA138292 (3), U10CA180820 (3), P30CA012197 (2), P30CA060553 (2), P30CA069533 (2), P50CA097186 (2), P50CA186786 (2), 2015 (1), 2016 (1), N01CN35157 (1), P30CA015083 (1), P30CA016058 (1)